Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 6/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | NR3C1 | P04150 | 8/20 | 0.49 |
| ▸ | NR3C2 | P08235 | 4/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | PGR | P06401 | 2/20 | 0.49 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | SHBG | P04278 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16387365 | 1.00 | HIF1A (0.51) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL16387355 | 0.89 | HIF1A (0.57) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL16387364 | 0.89 | HIF1A (0.57) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL16387356 | 0.85 | HIF1A (0.54) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL16387366 | 0.85 | HIF1A (0.54) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL16387349 | 0.82 | HIF1A (0.61) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL15079260 | 0.82 | HIF1A (0.61) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL16389277 | 0.80 | HIF1A (0.54) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL17634428 | 0.80 | HIF1A (0.54) | HIF1ALMNANR3C1NR3C2CYP2C19 | |
| SCHEMBL17591544 | 0.79 | HIF1A (0.57) | HIF1ALMNANR3C1NR3C2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150005518-A1 | PROCESS FOR ALKYNYLATING 16-SUBSTITUTED-17-KETO STEROIDS | CRYSTAL PHARMA, S.A.U. (ES) | 2015-01-01 | — | — | US | disclosed |
| US-20150005518-A1 | PROCESS FOR ALKYNYLATING 16-SUBSTITUTED-17-KETO STEROIDS | CRYSTAL PHARMA, S.A.U. (ES) | 2015-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005518-A1 | PROCESS FOR ALKYNYLATING 16-SUBSTITUTED-17-KETO STEROIDS | HSD17B7, NR3C2, CYP17A1 | HIF1A 3954/4885LMNA 553/4885NR3C1 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.